NCT00787657View on ClinicalTrials.gov

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

CompletedOBSERVATIONAL
Enrollment

1,723

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2013

Study Completion Date

October 31, 2014

Conditions
Relapsing Remitting Multiple Sclerosis (RRMS)
Interventions
DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

Patients after first clinical events suggestive of MS (according to SMPC) and patients with RRMS within the first two years of diagnosis

Trial Locations (36)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00787657 - Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment | Biotech Hunter | Biotech Hunter